EVALUATION OF HIGH-DOSE METHOTREXATE (MTX) WITH MINIMAL LEUCOVORIN RESCUE (LR) AND 5-FLUOROURACIL (5-FU) FOR SCHEDULE DEPENDENT SYNERGISM IN MAN

被引：0
|
作者：
WIEMANN, M
KAPLAN, H
STOLLER, R
HOKENESS, S
CUMMINGS, F
CALABRESI, P
机构：
[1] ROGER WILLIAMS GEN HOSP,PROVIDENCE,RI 02908
[2] BROWN UNIV,RHODE ISL HOSP,PROVIDENCE,RI 02908
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1979年 / 20卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [1] SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL (5-FU), AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU ALONE FOR ADVANCED COLORECTAL-CANCER - A MULTIINSTITUTIONAL RANDOMIZED TRIAL
    ABAD, A
    GARCIA, P
    GRAVALOS, C
    TUSQUETS, I
    FONT, A
    PEREZ, G
    CORTESFUNES, H
    FABREGAT, X
    BARNADAS, A
    ROSELL, R
    CANCER, 1995, 75 (06) : 1238 - 1244
  • [2] HIGH-DOSE METHOTREXATE (MTX) WITH MINIMAL LEUCOVORIN RESCUE (LR) - PHARMACOLOGIC STUDY
    STOLLER, RG
    CUMMINGS, FJ
    CALABRESI, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 344 - 344
  • [3] DOSE-DEPENDENT LEUCOVORIN EFFICACY WITH AN INTERMITTENT HIGH-DOSE 5-FLUOROURACIL SCHEDULE
    BRUCKNER, HW
    GLASS, LL
    CHESSER, MR
    CANCER INVESTIGATION, 1990, 8 (3-4) : 321 - 326
  • [4] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [5] TREATMENT OF ADVANCED COLORECTAL-CARCINOMA WITH HIGH-DOSE METHOTREXATE (HD-MTX) GIVEN ALONE AND IN COMBINATION WITH 5-FLUOROURACIL (5-FU)
    ISACOFF, WH
    TISMAN, G
    BLOCK, JB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 381 - 381
  • [6] EFFECT OF LEUCOVORIN ON SELECTIVE IMMUNOSUPPRESSION WITH METHOTREXATE (MTX) AND 5-FLUOROURACIL (5-FU) IN C3HEB-FEJ MICE
    DILORENZO, JA
    GRISWOLD, DE
    HEPPNER, GH
    CALABRESI, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 173 - 173
  • [7] Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer
    Lin, YC
    Chen, JS
    Wang, CH
    Wang, HM
    Chang, HK
    Liau, CT
    Yang, TS
    Liaw, CC
    Liu, HE
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 605 - 609
  • [8] HIGH DOSE METHOTREXATE (MTX) - HIGH DOSE 5-FLUOROURACIL (5FU) COMBINATION CHEMOTHERAPY FOR REFRACTORY MALIGNANCY
    TISMAN, G
    WU, SJG
    CLINICAL RESEARCH, 1979, 27 (01): : A54 - A54
  • [9] ALTERED PHARMACOKINETICS OF HIGH-DOSE 5-FLUOROURACIL (5-FU) WITH ALLOPURINOL (HPP) AND ANALYSIS OF ROUTES OF 5-FU ACTIVATION
    SCHWARTZ, PM
    HYDE, CM
    TUREK, PJ
    CADMAN, E
    HANDSCHUMACHER, RE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 222 - 222
  • [10] INITIAL CLINICAL AND PHARMACOKINETIC STUDY OF ORAL (PO) METHOTREXATE (MTX), INTRAVENOUS (IV) 5-FLUOROURACIL (5-FU) AND HIGH-DOSE FOLINIC ACID (FA)
    DENNY, A
    SLAVIK, M
    CHIEN, SC
    TAYLOR, S
    FABIAN, C
    STEPHENS, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 167 - 167
12345